![TY Howton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
TY Howton
Directeur des opérations chez
SOLID BIOSCIENCES INC.
Fortune : 846 921 $ au 31/07/2026
Profil
David Tyronne Howton is Director at Biogene Therapeutics, Inc. since 2026.
Mr. Howton is Chief Operating Officer & Secretary at Solid Biosciences, Inc. since 2023.
Former roles include Director at Make-A-Wish Foundation of Massachusetts, Chief Healthcare Compliance Officer at Genentech, Inc., Secretary, Chief Legal Officer & Senior VP at Vertex Pharmaceuticals, Inc. in 2012, Secretary, Senior Vice President & General Counsel at Sarepta Therapeutics, Inc. from 2013 to 2020, and Chief Operating Officer & General Counsel at AavantiBio, Inc. from 2021 to 2022.
Education includes undergraduate studies at Yale University and graduate studies at Northwestern University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 105 077 ( 0,11% ) | 846 921 $ | 31/07/2026 |
Postes actifs de TY Howton
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur des opérations | 01/09/2023 |
Anciens postes connus de TY Howton
| Sociétés | Poste | Fin |
|---|---|---|
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Directeur des opérations | 01/12/2022 |
| SAREPTA THERAPEUTICS, INC. | Conseiller Juridique Général | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Conseiller Juridique Général | 12/06/2012 |
Make-A-Wish Foundation of Massachusetts | Directeur/Membre du Conseil | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Formation de TY Howton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Make-A-Wish Foundation of Massachusetts | |
Northwestern University School of Law
 Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
